These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26304825)

  • 21. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Pneumococcal Vaccination Rates in High-risk Children in Specialty Clinics.
    Harris JG; Harris LA; Olarte L; Elson EC; Moran R; Blowey DL; El Feghaly RE
    Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35233616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.
    Grogg SE; Schultz J
    J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.
    Jiang Y; Gauthier A; Keeping S; Carroll S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):913-27. PubMed ID: 25189087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.
    Harboe ZB; Dalby T; Weinberger DM; Benfield T; Mølbak K; Slotved HC; Suppli CH; Konradsen HB; Valentiner-Branth P
    Clin Infect Dis; 2014 Oct; 59(8):1066-73. PubMed ID: 25034421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing a Nurse-Driven Protocol for Pneumococcal Vaccination in an Academic Rheumatology Clinic.
    Joerns EK; Pokala N; Bermas B; Reisch J; Wang DC; Arasaratnam R; Bajaj P
    J Rheumatol; 2023 Mar; 50(3):413-419. PubMed ID: 36319017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of various types of patients' reminders on the uptake of pneumococcal vaccine in adults: A randomized controlled trial.
    Ghadieh AS; Hamadeh GN; Mahmassani DM; Lakkis NA
    Vaccine; 2015 Oct; 33(43):5868-5872. PubMed ID: 26232345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 13-valent pneumococcal conjugate vaccine.
    Prescrire Int; 2011 Jan; 20(112):5-7, 9. PubMed ID: 21462782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
    Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
    Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving Pneumococcal Vaccination Rates in Rheumatology Patients by Using Best Practice Alerts in the Electronic Health Records.
    Sheth HS; Grimes VD; Rudge D; Ayers B; Moreland LW; Fischer GS; Aggarwal R
    J Rheumatol; 2021 Sep; 48(9):1472-1479. PubMed ID: 33323531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacist-driven academic detailing program to increase adult pneumococcal vaccination.
    Caffrey AR; DeAngelis JM; Ward KE; Orr KK; Morrill HJ; Gosciminski M; LaPlante KL;
    J Am Pharm Assoc (2003); 2018; 58(3):303-310. PubMed ID: 28951137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.
    Paradiso PR
    Clin Infect Dis; 2011 May; 52(10):1241-7. PubMed ID: 21507921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
    Gladstone RA; Jefferies JM; Faust SN; Clarke SC
    Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
    Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
    Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.